Motif Bio PLC Company Profile (LON:MTFB)

About Motif Bio PLC (LON:MTFB)

Motif Bio PLC logoMotif Bio plc is a clinical-stage biopharmaceutical company. The Company is engaged in development of antibiotics, which are designed for treatment of infections caused by multi-drug resistant bacteria. It operates in the development and commercialization of pharmaceutical formulations segment. The Company is focused on development of its product, Iclaprim, for the treatment of the bacterial infections, such as acute bacterial skin and skin structure infections (ABSSSI) and hospital acquired bacterial pneumonia (HABP), including those caused by resistant strains, such as methicillin-resistant Staphylococcus aureus (MRSA) and multi-drug resistant Streptococcus pneumonia (MDRSP). Iclaprim exhibits potent activity against Gram-positive clinical isolates of various genera of staphylococci. It intends to build a portfolio of antibiotics by licensing drug candidates from organizations specializing in antibacterial research, and is pursuing programs in various stages of development.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: N/A
  • Symbol: LON:MTFB
  • CUSIP: N/A
  • Web: https://www.motifbio.com/
Capitalization:
  • Market Cap: £55.34 million
  • Outstanding Shares: 195,885,000
Average Prices:
  • 50 Day Moving Avg: GBX 29.12
  • 200 Day Moving Avg: GBX 29.35
  • 52 Week Range: GBX 21.44 - GBX 57
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: N/A
  • Price / Sales: N/A
  • Book Value: GBX 0.05 per share
  • Price / Book: 5.65
Profitability:
  • Return on Equity: -418.79%
  • Return on Assets: -192.49%
Misc:
  • Average Volume: 945,343 shs.
 

Frequently Asked Questions for Motif Bio PLC (LON:MTFB)

What is Motif Bio PLC's stock symbol?

Motif Bio PLC trades on the London Stock Exchange (LON) under the ticker symbol "MTFB."

Where is Motif Bio PLC's stock going? Where will Motif Bio PLC's stock price be in 2017?

4 equities research analysts have issued twelve-month price objectives for Motif Bio PLC's stock. Their forecasts range from GBX 90 to GBX 110. On average, they anticipate Motif Bio PLC's share price to reach GBX 100 in the next twelve months. View Analyst Ratings for Motif Bio PLC.

Who are some of Motif Bio PLC's key competitors?

Who are Motif Bio PLC's key executives?

Motif Bio PLC's management team includes the folowing people:

  • Graham George Lumsden, Chief Executive Officer, Executive Director
  • Robert Dickey IV, Chief Financial Officer
  • Rajesh B. Shukla, Vice President - Clinical Operations
  • Robert J. Bertoldi, Executive Director
  • David Huang M.D. Ph.D., Chief Medical Officer
  • Stephen Austin, Company Secretary
  • Richard Cecil Eversfield Morgan, Non-Executive Chairman of the Board
  • Craig T. Albanese, Non-Executive Director
  • Charlotta Ginman-Jones, Non-Executive Director
  • Jonathan E Gold, Non-Executive Director

How do I buy Motif Bio PLC stock?

Shares of Motif Bio PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Motif Bio PLC's stock price today?

One share of Motif Bio PLC stock can currently be purchased for approximately GBX 28.25.


MarketBeat Community Rating for Motif Bio PLC (LON MTFB)
Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  152 (Vote Outperform)
Underperform Votes:  112 (Vote Underperform)
Total Votes:  264
MarketBeat's community ratings are surveys of what our community members think about Motif Bio PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Motif Bio PLC (LON:MTFB) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: GBX 100

Analysts' Ratings History for Motif Bio PLC (LON:MTFB)
Show:
DateFirmActionRatingPrice TargetDetails
8/9/2017Northland SecuritiesReiterated RatingBuyView Rating Details
8/9/2017FinnCapReiterated RatingBuyGBX 100View Rating Details
6/5/2017Beaufort SecuritiesReiterated RatingSpeculative BuyGBX 110View Rating Details
1/9/2017Rodman & RenshawInitiated CoverageBuyView Rating Details
11/11/2015Northland Capital PartnersReiterated RatingBuyGBX 114View Rating Details
(Data available from 8/22/2015 forward)

Earnings

Earnings History for Motif Bio PLC (LON:MTFB)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Motif Bio PLC (LON:MTFB)
Current Year EPS Consensus Estimate: $-25.11 EPS

Dividends

Dividend History for Motif Bio PLC (LON:MTFB)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Motif Bio PLC (LON:MTFB)
Insider Trades by Quarter for Motif Bio PLC (LON:MTFB)
Insider Trades by Quarter for Motif Bio PLC (LON:MTFB)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/5/2015Stakes III,John WilburInsiderBuy100,000GBX 60£60,000
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Motif Bio PLC (LON:MTFB)
Latest Headlines for Motif Bio PLC (LON:MTFB)
Source:
DateHeadline
americanbankingnews.com logoMotif Bio PLC's (MTFB) Buy Rating Reaffirmed at Northland Securities
www.americanbankingnews.com - July 9 at 9:24 AM
nasdaq.com logoMotif Bio Announces Result of General Meeting and Total Voting Rights
www.nasdaq.com - June 23 at 7:10 PM
globenewswire.com logoMotif Bio Announces Result of General Meeting and Total Voting Rights - GlobeNewswire (press release)
globenewswire.com - June 23 at 8:14 AM
americanbankingnews.com logoMotif Bio PLC (MTFB) PT Lowered to GBX 100
www.americanbankingnews.com - June 7 at 11:04 PM
americanbankingnews.com logoMotif Bio PLC (MTFB) Earns "Speculative Buy" Rating from Beaufort Securities
www.americanbankingnews.com - June 5 at 1:08 PM
americanbankingnews.com logoMotif Bio PLC (MTFB) Given "Corporate" Rating at Northland Securities
www.americanbankingnews.com - June 2 at 1:14 PM
globenewswire.com logoMotif Bio Appoints Scientific Opinion Leaders to Advisory Board - GlobeNewswire (press release)
globenewswire.com - May 10 at 6:44 PM
nasdaq.com logoMotif Bio Appoints Scientific Opinion Leaders to Advisory Board
www.nasdaq.com - May 10 at 12:15 PM
nasdaq.com logoEuropean ADRs Rally, Buoyed by Banking Stocks
www.nasdaq.com - April 24 at 12:14 PM
americanbankingnews.com logoMotif Bio PLC's (MTFB) "Buy" Rating Reiterated at Northland Securities
www.americanbankingnews.com - April 24 at 6:26 AM
americanbankingnews.com logoMotif Bio PLC (MTFB) Given Speculative Buy Rating at Beaufort Securities
www.americanbankingnews.com - April 23 at 6:16 PM
americanbankingnews.com logoRodman & Renshaw Initiates Coverage on Motif Bio PLC (MTFB)
www.americanbankingnews.com - April 15 at 4:10 PM
americanbankingnews.com logoMotif Bio PLC (MTFB) Now Covered by FinnCap
www.americanbankingnews.com - April 8 at 11:15 PM
lse.co.uk logoClinical trial finishes patient treatment phase - London South East (registration) (blog)
www.lse.co.uk - January 31 at 7:37 PM
globenewswire.com logoMotif Bio Phase 3 Clinical Trial Finishes Patient Treatment Phase - GlobeNewswire (press release)
globenewswire.com - January 30 at 7:24 PM
nasdaq.com logoMotif Bio plc Announces Closing of its $25 Million U.S. Initial Public Offering and European Placement
www.nasdaq.com - November 23 at 6:22 PM
247wallst.com logoMarijuana REIT to Test IPO Market This Week
247wallst.com - November 20 at 6:02 PM
lse.co.uk logoConfirms successful European placing - London South East (registration) (blog)
www.lse.co.uk - November 19 at 6:23 PM
streetinsider.com logoMotif Bio plc (MTFB) IPO Opens Lower - StreetInsider.com
www.streetinsider.com - November 19 at 6:23 PM
streetinsider.com logoMotif Bio plc (MTFB) IPO Opens Lower
www.streetinsider.com - November 19 at 8:57 AM
finance.yahoo.com logoMotif Bio plc Announces Pricing Of $25 Million U.S. Initial Public Offering and European Placing
finance.yahoo.com - November 18 at 9:16 AM
247wallst.com logoNo IPOs Last Week, All Postponed Until This Week - 24/7 Wall St.
247wallst.com - November 13 at 10:21 AM
247wallst.com logoIPO Calendar Thins Out for Election Week
247wallst.com - November 7 at 10:06 AM
uk.finance.yahoo.com logoHigh-level changes at Motif Bio
uk.finance.yahoo.com - November 6 at 6:47 PM
247wallst.com logoIPO Calendar Thins Out for Election Week - 24/7 Wall St.
247wallst.com - November 6 at 10:56 AM
seekingalpha.com logoMotif Bio Is Well Run But Too Risky
seekingalpha.com - September 21 at 10:23 AM

Social

Social activity is not available for this stock.

Chart

Motif Bio PLC (MTFB) Chart for Tuesday, August, 22, 2017

This page was last updated on 8/22/2017 by MarketBeat.com Staff